Understanding how gestational diabetes affects immunity and infections during pregnancy

Characterizing the Impact of Gestational Diabetes on Immunity and Group B Streptococcal Virulence in the Maternal Reproductive Tract

NIH-funded research Baylor College of Medicine · NIH-10992632

This study is looking at how gestational diabetes might make pregnant women more likely to get infections from group B Streptococcus (GBS), and it aims to find out why this happens so we can improve ways to prevent and treat these infections for moms and their babies.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10992632 on NIH RePORTER

What this research studies

This research investigates the relationship between gestational diabetes and the risk of infections caused by group B Streptococcus (GBS) in pregnant women. It aims to uncover the mechanisms that make women with gestational diabetes more susceptible to GBS, which can lead to serious complications for both mothers and their babies. Using a specialized mouse model, the study will explore how GBS ascends in the reproductive tract and the immune responses involved. The findings could lead to better prevention and treatment strategies for GBS infections in pregnant women.

Who could benefit from this research

Good fit: Ideal candidates for this research are pregnant women diagnosed with gestational diabetes who are at increased risk for group B Streptococcus infections.

Not a fit: Patients who are not pregnant or those without gestational diabetes may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment options for pregnant women with gestational diabetes, reducing the risk of severe infections and complications for both mothers and infants.

How similar studies have performed: Previous research has shown that understanding the microbiota and immune responses in pregnancy can lead to significant advancements in maternal and neonatal health, indicating potential success for this approach.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Candidate Disease Gene
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.